131 related articles for article (PubMed ID: 8127921)
1. Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention.
Krähenbühl S
Pharmacol Ther; 1993 Oct; 60(1):1-38. PubMed ID: 8127921
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria in chronic liver disease.
Grattagliano I; Russmann S; Diogo C; Bonfrate L; Oliveira PJ; Wang DQ; Portincasa P
Curr Drug Targets; 2011 Jun; 12(6):879-93. PubMed ID: 21269263
[TBL] [Abstract][Full Text] [Related]
3. Re-wiring the circuit: mitochondria as a pharmacological target in liver disease.
Diogo CV; Grattagliano I; Oliveira PJ; Bonfrate L; Portincasa P
Curr Med Chem; 2011; 18(35):5448-65. PubMed ID: 22087837
[TBL] [Abstract][Full Text] [Related]
4. Adaptation of mitochondrial metabolism in liver cirrhosis. Different strategies to maintain a vital function.
Krähenbühl S; Reichen J
Scand J Gastroenterol Suppl; 1992; 193():90-6. PubMed ID: 1290065
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial energy metabolism impairment and liver dysfunction following chronic exposure to dichlorvos.
Binukumar BK; Bal A; Kandimalla R; Sunkaria A; Gill KD
Toxicology; 2010 Apr; 270(2-3):77-84. PubMed ID: 20132858
[TBL] [Abstract][Full Text] [Related]
6. Relationship between hepatic mitochondrial functions in vivo and in vitro in rats with carbon tetrachloride-induced liver cirrhosis.
Krähenbühl L; Ledermann M; Lang C; Krähenbühl S
J Hepatol; 2000 Aug; 33(2):216-23. PubMed ID: 10952239
[TBL] [Abstract][Full Text] [Related]
7. Central role of mitochondria in drug-induced liver injury.
Pessayre D; Fromenty B; Berson A; Robin MA; Lettéron P; Moreau R; Mansouri A
Drug Metab Rev; 2012 Feb; 44(1):34-87. PubMed ID: 21892896
[TBL] [Abstract][Full Text] [Related]
8. Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte.
Krähenbühl S; Krähenbühl-Glauser S; Stucki J; Gehr P; Reichen J
Hepatology; 1992 Jun; 15(6):1167-72. PubMed ID: 1592355
[TBL] [Abstract][Full Text] [Related]
9. Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.
Hidaka I; Hino K; Korenaga M; Gondo T; Nishina S; Ando M; Okuda M; Sakaida I
Liver Int; 2007 Aug; 27(6):845-53. PubMed ID: 17617128
[TBL] [Abstract][Full Text] [Related]
10. Disorders of the mitochondria.
Treem WR; Sokol RJ
Semin Liver Dis; 1998; 18(3):237-53. PubMed ID: 9773424
[TBL] [Abstract][Full Text] [Related]
11. 13C-breath tests in the study of mitochondrial liver function.
Candelli M; Cazzato IA; Zocco MA; Nista EC; Fini L; Armuzzi A; Camise V; Santoro M; Miele L; Grieco A; Gasbarrini G; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2004; 8(1):23-31. PubMed ID: 15209152
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.
Ong MM; Latchoumycandane C; Boelsterli UA
Toxicol Sci; 2007 May; 97(1):205-13. PubMed ID: 17150972
[TBL] [Abstract][Full Text] [Related]
13. Aluminum chloride caused liver dysfunction and mitochondrial energy metabolism disorder in rat.
Xu F; Liu Y; Zhao H; Yu K; Song M; Zhu Y; Li Y
J Inorg Biochem; 2017 Sep; 174():55-62. PubMed ID: 28605655
[TBL] [Abstract][Full Text] [Related]
14. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.
Serviddio G; Bellanti F; Tamborra R; Rollo T; Capitanio N; Romano AD; Sastre J; Vendemiale G; Altomare E
Gut; 2008 Jul; 57(7):957-65. PubMed ID: 18308829
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial abnormalities in non-alcoholic steatohepatitis.
Caldwell SH; Swerdlow RH; Khan EM; Iezzoni JC; Hespenheide EE; Parks JK; Parker WD
J Hepatol; 1999 Sep; 31(3):430-4. PubMed ID: 10488700
[TBL] [Abstract][Full Text] [Related]
16. Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury.
Devi BG; Chan AW
Life Sci; 1997; 60(11):849-55. PubMed ID: 9076324
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial and liver oxidative stress alterations induced by N-butyl-N-(4-hydroxybutyl)nitrosamine: relevance for hepatotoxicity.
Oliveira MM; Teixeira JC; Vasconcelos-Nóbrega C; Felix LM; Sardão VA; Colaço AA; Oliveira PA; Peixoto FP
J Appl Toxicol; 2013 Jun; 33(6):434-43. PubMed ID: 22095756
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status.
Vendemiale G; Grattagliano I; Caraceni P; Caraccio G; Domenicali M; Dall'Agata M; Trevisani F; Guerrieri F; Bernardi M; Altomare E
Hepatology; 2001 Apr; 33(4):808-15. PubMed ID: 11283843
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular toxicity of benzbromarone: effects on mitochondrial function and structure.
Felser A; Lindinger PW; Schnell D; Kratschmar DV; Odermatt A; Mies S; Jenö P; Krähenbühl S
Toxicology; 2014 Oct; 324():136-46. PubMed ID: 25108121
[TBL] [Abstract][Full Text] [Related]
20. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B.
Honkoop P; de Man RA; Scholte HR; Zondervan PE; Van Den Berg JW; Rademakers LH; Schalm SW
Hepatology; 1997 Jul; 26(1):211-5. PubMed ID: 9214472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
